Over a century before the mis-marketing of OxyContin dominated news outlets, the nation faced its first widespread opioid epidemic. The emergence, exploitation, and eruption of both epidemics follow the same arcs in history, yet the de-escalation of the 19th century epidemic has faded into distant memory and recovery from the most recent has yet to be seen.
During the first epidemic, pharmaceutical companies and federal regulations laid the groundwork for the stigmatization of opioid addiction that created an isolating environment for those struggling with opioid dependence today. Accessible recovery in conjunction with de-stigmatizing what was left by the earlier epidemic is needed to prevent future devastation and build a system that can prevent history from repeating itself once again.
Alleviating future escalation of the modern opioid crisis requires understanding the onset of the first opioid epidemic, sympathizing with the physiology of addiction, and making proven treatments such as MAT, or Medication-Assisted Treatment, widely available. In Crisis, Again visualizes each of these factors necessary for the nation’s recovery and tells the story of opioid’s overwhelming grip on the United States since its inception.
- U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2022). Find Medication-Assisted Treatment (MAT). Retrieved from https://www.samhsa.gov/medication-assisted-treatment/find-treatment
- U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2018). Statutes Regulations Guidelines.. Retrieved from https://www.samhsa.gov/medication-assisted-treatment/statutes-regulations-guidelines
- U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2022). Find Medication-Assisted Treatment (MAT). Retrieved from https://www.samhsa.gov/medication-assisted-treatment/find-treatment
- Centers for Disease Control and Prevention. U.S. Opioid Dispensing Rate Maps (2012) https://www.cdc.gov/drugoverdose/rxrate-maps/index.html#:~:text=The%20overall%20national%20opioid%20dispensing%20rate%20declined%20from%202012%20to,than%20142%20million%20opioid%20prescriptions).
- Substance Abuse and Mental Health Services Administration Opioid treatment program directory. http://dpt2.samhsa.gov/treatment/directory.aspx. Accessed April 2022.
- Centers for Disease Control and Prevention Multiple cause of death data. https://wonder.cdc.gov/mcd.html. Accessed April 2022.
- Drilling into the Dea’s pain pill database. (2019, July 16). The Washington Post. Retrieved from https://www.washingtonpost.com/graphics/2019/investigations/dea-pain-pill-database/?utm_term=.07de4b1a18eb&itid=lk_interstitial_manual_23.
- Evans, W. N., Lieber, E. M., & Power, P. (2019). How the reformulation of OxyContin ignited the heroin epidemic. The Review of Economics and Statistics, 101(1), 1–15. https://doi.org/10.1162/rest_a_00755
- Jick, H., & Porter, J. (1980). Addiction rare in patients treated with narcotics. New England Journal of Medicine, 302(2), 123–123. https://doi.org/10.1056/nejm198001103020221
- Macy, B. (2018). Dopesick: Dealers, doctors, and the company that addicted america. Little, Brown and Company.
- Meier, B. (2020). Pain Killer. Hachette Australia.
- Quinones, S. (2019). Dreamland. Bloomsbury Publishing.
- Van Zee, A. (2009). The promotion and marketing of Oxycontin: Commercial Triumph, public health tragedy. American Journal of Public Health, 99(2), 221–227. https://doi.org/10.2105/ajph.2007.131714
- Caton D. The secularization of pain. Anesthesiology. 1985;62(4):493-501. doi: 10.1097/00000542-198504000-00020.
- Hoffman, Jan. C.D.C. Proposes New Guidelines for Treating Pain, Including Opioid Use.2022.
- Haffajee, R. L., Lin, L. A., Bohnert, A. S. B., & Goldstick, J. E. (2019, June 5). Characteristics of us counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA network open. Retrieved May 15, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604101/
- Hirsch, Jennifer, Charles Branas, and Helena Hansen. “The Opioid Crisis: What We Should Learn from the AIDS Epidemic | Columbia Public Health.” www.publichealth.columbia.edu, January 4, 2019. https://www.publichealth.columbia.edu/public-health-now/news/opioid-crisis-what-we-should-learn-aids-epidemic.
- Solutions, InSync Healthcare. “The History of the Opioid Epidemic.” www.insynchcs.com, n.d. https://www.insynchcs.com/blog/the-history-of-the-opioid-epidemic.
- Sinha, Shreeya, Zach Lieberman, Leslye Davis, Jennifer Harlan, and Rumsey Taylor. “Heroin Addiction Explained: How Opioids Hijack the Brain.” The New York Times, December 19, 2018, sec. U.S. https://www.nytimes.com/interactive/2018/us/addiction-heroin-opioids.html?action=click&pgtype=Article&state=default&module=styln-opioid&variant=show®ion=MAIN_CONTENT_1&block=storyline_top_links_recirc.
- Trickey, Erick. “Inside the Story of America’s 19th-Century Opiate Addiction.” Smithsonian. Smithsonian.com, January 4, 2018. https://www.smithsonianmag.com/history/inside-story-americas-19th-century-opiate-addiction-180967673/.
- Ruane, Michael E. “America’s First Opioid Crisis Grew out of the Carnage of the Civil War.” Washington Post, December 1, 2021. https://www.washingtonpost.com/history/2021/12/01/opioid-crisis-civil-war-addiction/.